Galapagos | 销售和管理费用

Selling And Administration Expenses 更改 日
AstraZeneca USD 3.91B 194M 2023-09
Biogen USD 608.5M 179.7M 2023-12
Genmab DKK 839M 9M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
GRIFOLS EUR 353.2M 52.88M 2023-12
Hikma Pharmaceutical USD 260M 7M 2023-06
Incyte USD 293.86M 25.97M 2023-12
Merck EUR 1.42B 68M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Roche Holding CHF 6.51B 26M 2023-06
UCB EUR 857M 12M 2023-06
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Galapagos 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.